← All indications
Respiratory Insufficiency
Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)
Subtype terms (9)
More specific conditions that are subtypes of Respiratory Insufficiency in the MeSH hierarchy.
- Acidosis, Respiratory
2 drugs approved
- Airway Obstruction
19 drugs (18 approved, 1 experimental)
- Brief, Resolved, Unexplained Event
- Granuloma, Laryngeal
2 drugs approved
- Hantavirus Pulmonary Syndrome
1 drug approved
- Hypoventilation
3 drugs approved
- Patient-Ventilator Asynchrony
- Positive-Pressure Respiration, Intrinsic
- Respiratory Paralysis
2 drugs approved
Drugs by status
Approved for this indication (5)
Phase 4 trials (35)
- propofol
- heparin
- acetazolamide
- argatroban
- butorphanol
- ketamine
- cisatracurium
- oxycodone
- helium
- levocarnitine
- oliceridine
- ropivacaine
- poractant alfa
- caffeine
- remimazolam
- rocuronium
- cannabis
- sofosbuvir
- beractant
- hydromorphone
- enoxaparin
- velpatasvir
- dexmedetomidine
- pibrentasvir
- fentanyl
- neostigmine
- oxygen
- morphine
- lansoprazole
- sugammadex
- +5 more
Phase 3 trials (25)
Phase 2 trials (29)
- vitamin d3
- colfosceril palmitate
- tenecteplase
- iloprost
- etomidate
- ganciclovir
- citrulline
- vitamin c
- fondaparinux sodium
- pb1046
- mefloquine
- sirolimus
- acetylsalicylic acid
- alteplase
- tocilizumab
- thiamine
- alprostadil
- palmitic acid
- sildenafil
- clopidogrel
- telmisartan
- sinapultide
- milrinone
- tirofiban
- phosphatidylglycerol
- dextrose
- COVID-19 convalescent plasma
- mrg001
- ENA-001
Phase 1 trials (14)
Organizations
Organization Involved with Phase 4 Indications (39)
- Mallinckrodt
- Fondazione Poliambulanza Istituto Ospedaliero
- Baylor University
- Centre Hospitalier Universitaire de Nīmes
- University of London
- Harvard University
- Mahidol University
- Northwestern University
- Ospedale Regionale di Locarno
- Pierre and Marie Curie University
- Texas Tech University
- University of Florida
- University of Oslo
- University of Pavia
- University of Bologna
- Mayo Clinic
- Aalborg University
- Far Eastern Memorial Hospital
- Poznan University
- University of California, Davis
- University of Copenhagen
- University of Debrecen
- Leiden University
- Free University of Amsterdam
- University of Limoges
- Louisiana State University
- Osakidetza
- Mario Negri Institute
- University of Texas at Houston
- Jawaharlal Institute of Postgraduate Medical Education and Research
- +9 more
Organization Involved with Phase 3 Indications (87)
- Abivax S.A.
- Takeda
- Organon
- AstraZeneca
- Bayer
- BioDelivery Sciences International
- Chimerix
- Swiss National Science Foundation
- ZonMw: The Netherlands Organisation for Health Research and Development
- National Institutes of Health (NIH)
- National Center for Research Resources (NCRR)
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Pennsylvania
- Australian National University
- Brown University
- Case Western Reserve University
- Centre Hospitalier of Chartres
- Emory University
- Federal University of Minas Gerais
- University of Washington
- Henan University of Traditional Chinese Medicine
- Indiana University
- Katholieke Universiteit Leuven
- KK Women's and Children's Hospital
- Masaryk University
- McGill University
- McMaster University
- Medical College of Wisconsin
- Palacky University
- Queen's University, Belfast
- +57 more
Organization Involved with Phase 2 Indications (68)
- Asklepion
- Actelion
- UCB
- Theravance
- Genentech
- Pfizer
- Mylan
- Novartis
- Hamad Medical Corporation
- Hope Pharmaceuticals
- Paion UK Ltd.
- PhaseBio Pharmaceuticals Inc.
- RespireRx
- Windtree Therapeutics
- Fundación de investigación HM
- Burnasyan Federal Medical Biophysical Center
- National Institute of Nursing Research (NINR)
- National Polytechnic Institute, Mexico
- Region Skane
- Aarhus University
- Duke University
- Temple University
- Johns Hopkins University
- New York University
- Ohio State University
- RTI International
- Tufts University
- University of Iowa
- University of Milan
- University of South Alabama
- +38 more
Organization Involved with Phase 1 Indications (11)
- University of Pittsburgh
- Cedars-Sinai Medical Center
- Postgraduate Institute of Medical Education and Research
- Stony Brook University
- University of California, San Francisco
- Food and Drug Administration
- Spaulding Clinical Research Inc.
- Pharmaceutical Research Associates, Inc. (PRA)
- Methodist Cancer Center, Houston, Texas
- Government of Finland
- ReAlta Life Sciences, Inc.
Organization Involved with Other Experimental Indications (28)
- Novo Nordisk
- NeuroRx, Inc.
- University of Arizona
- Lund University
- MemorialCare Health System
- Oregon Health and Science University
- Sichuan University
- University of Zurich
- Assiut University
- Columbia University
- Genesys
- Genesys Regional Medical Center
- Laval University
- University of Basel
- Long Beach Memorial Medical Center
- Jiao Tong University
- Cook Children's Medical Center
- Universidad de los Andes
- Technion University
- University of Sao Paulo
- Moorgreen Hospital, Southampton
- University of Western Ontario
- National Institute for Health Research, United Kingdom
- Memorial Medical Center Foundation
- American Medical Association
- Yeshiva University
- Royal Free Charity
- Cavendish Impact Foundation